XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Earnings (Loss) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2024
Mar. 30, 2023
Revenues:    
Revenues other than cost reimbursements $ 129,369 $ 142,748
Cost reimbursements 9,178 9,528
Total revenues 138,547 152,276
Costs and expenses:    
Advertising and marketing 5,301 5,065
Administrative 21,402 19,851
Depreciation and amortization 16,015 15,876
Rent 6,347 6,493
Property taxes 3,931 4,757
Other operating expenses 9,870 9,651
Loss on disposition of property, equipment and other assets 23 398
Reimbursed costs 9,178 9,528
Total costs and expenses 155,212 161,264
Operating loss (16,665) (8,988)
Other income (expense):    
Investment income 692 260
Interest expense (2,534) (3,008)
Other income (expense) (341) (401)
Equity losses from unconsolidated joint ventures (387) (171)
Nonoperating income (expense), total (2,570) (3,320)
Loss before income taxes (19,235) (12,308)
Income tax benefit (7,369) (2,842)
Net loss $ (11,866) $ (9,466)
Common Stock    
Net loss per share - basic:    
Net loss per share - basic (in dollars per share) $ (0.38) $ (0.31)
Net loss per share - diluted:    
Net loss per share - diluted (in dollars per share) (0.38) (0.31)
Class B Common Stock    
Net loss per share - basic:    
Net loss per share - basic (in dollars per share) (0.34) (0.28)
Net loss per share - diluted:    
Net loss per share - diluted (in dollars per share) $ (0.34) $ (0.28)
Theatre admissions    
Revenues:    
Revenues $ 40,596 $ 47,635
Rooms    
Revenues:    
Revenues 18,213 17,857
Costs and expenses:    
Costs 9,411 9,278
Theatre concessions    
Revenues:    
Revenues 34,695 42,375
Costs and expenses:    
Costs 14,886 15,730
Food and beverage    
Revenues:    
Revenues 16,163 15,193
Costs and expenses:    
Costs 13,863 13,568
Other revenues    
Revenues:    
Revenues 19,702 19,688
Theatre operations    
Costs and expenses:    
Costs $ 44,985 $ 51,069